EMA recommends approval of Revolution’s pancreatic cancer drug
The European Medicines Agency on Thursday recommended approval of Revolution Medicines’ pancreatic cancer drug Rasonque in the EU.
The European Medicines Agency on Thursday recommended approval of Revolution Medicines’ pancreatic cancer drug Rasonque in the EU.